This ruling resolves all issues in this case with Mannatech winning on all patent and trademark infringement claims brought against Glycoproducts International (Glycobiotics). The judge also entered a
In its first application the company will be focusing on creating novel monoclonal antibodies (MAbs) against cancer markers (the ‘MAbs Technology’). The acquisition was made pursuant to an
Teva expects to receive Momenta and Sandoz’s Paragraph IV certification notice referring to Teva’s US patents, which cover the chemical composition of Copaxone, pharmaceutical compositions containing it, and
The Opposition Division of the European Patent Office, following a three-day hearing, announced its decision to revoke the European patent exclusively licensed to Alnylam Pharmaceuticals from Cancer Research
Each investment unit consists of a share of common stock, two series of common stock purchase warrants to purchase 0.5 share of common stock respectively. The offering of
Under the terms of the agreement, GlaxoSmithKline (GSK) will receive exclusive worldwide rights to co-develop and co-commercialize almorexant. Actelion will continue to lead the ongoing development program and
The decision followed a planned interim analysis of studies C-02-60 A and B that was performed after 2,546 patients had completed the 24 month time point. In this
Over the last two years Mr Prichard served as CFO of ProMetic BioSciences, its UK division and in addition assumed the role of vice president of corporate development
The new facility is 5,760 square feet, and most of this space is said to be targeted for future company growth. In addition, Critical Path Services (CPS) will
The new facilities will offer the full-range of infectious disease testing for transplant organizations in these regions. By opening these laboratories, Labs now allows local and regional organ
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.